CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 44 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,378,685 | -39.4% | 2,027,000 | -19.8% | 0.07% | -36.5% |
Q2 2023 | $3,922,409 | -3.7% | 2,527,000 | -22.6% | 0.10% | -5.5% |
Q1 2023 | $4,072,166 | +8.3% | 3,264,000 | 0.0% | 0.11% | +8.9% |
Q4 2022 | $3,759,802 | -2.7% | 3,264,000 | -8.4% | 0.10% | -8.2% |
Q3 2022 | $3,865,000 | -10.4% | 3,564,000 | 0.0% | 0.11% | -6.0% |
Q2 2022 | $4,312,000 | -29.7% | 3,564,000 | 0.0% | 0.12% | -17.0% |
Q1 2022 | $6,134,000 | +2.2% | 3,564,000 | -1.3% | 0.14% | +15.6% |
Q4 2021 | $6,004,000 | -22.6% | 3,611,000 | -27.8% | 0.12% | -27.8% |
Q3 2021 | $7,762,000 | -7.8% | 4,998,000 | -4.0% | 0.17% | -11.1% |
Q2 2021 | $8,417,000 | -14.2% | 5,208,000 | -17.0% | 0.19% | -17.7% |
Q1 2021 | $9,814,000 | +32.9% | 6,271,000 | +19.0% | 0.23% | +22.2% |
Q4 2020 | $7,387,000 | +25.1% | 5,271,000 | 0.0% | 0.19% | +8.0% |
Q3 2020 | $5,903,000 | +39.4% | 5,271,000 | +31.4% | 0.18% | +29.6% |
Q2 2020 | $4,234,000 | +24.3% | 4,010,000 | +9.9% | 0.14% | +12.5% |
Q1 2020 | $3,407,000 | – | 3,650,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mohican Financial Management, LLC | 2,840,000 | $3,958,000 | 4.02% |
ZAZOVE ASSOCIATES LLC | 13,564,000 | $18,956,000 | 2.33% |
SHENKMAN CAPITAL MANAGEMENT INC | 10,584,000 | $15,014,000 | 1.57% |
SSI INVESTMENT MANAGEMENT LLC | 8,349,000 | $11,673,000 | 0.83% |
OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $12,528,000 | 0.75% |
MACKAY SHIELDS LLC | 32,384,000 | $45,397,000 | 0.31% |
ADVENT CAPITAL MANAGEMENT /DE/ | 8,379,000 | $11,734,000 | 0.25% |
PALISADE CAPITAL MANAGEMENT, LP | 5,271,000 | $7,387,000 | 0.19% |
Calamos Advisors LLC | 23,007,000 | $32,262,000 | 0.19% |
WESTWOOD HOLDINGS GROUP INC | 10,200,000 | $14,415,000 | 0.17% |